Publication at First Faculty of Medicine |
2020
Abstract
Glucose sensors have become a common part of diabetes care in patients with type 1 diabetes (T1D). Regular usage of real-time continuous glucose monitoring (rt-CGM) reduces the incidence of hypoglycaemia, decreases glycated hemoglobin and glycemic variability and improves time in range.
The basic component of conventional rt-CGM is a transdermal sensor, which consists of an internal measuring part (electrode) and an external part for transmitter. In contrast with traditional rt-CGM the new impantable sensor is implanted entirely under the skin after a small incision.
The following text provides an overview of basic knowledge of a new way of glucose monitoring.